Melanoma Brain Metastases and Vemurafenib: Need for Further Investigation

Brain metastases are a major cause of morbidity and mortality in patients with advanced melanoma. With the development of targeted agents for the treatment of metastatic melanoma, a great deal of interest has focused on whether selective BRAF inhibitors may play a role in the treatment of brain meta...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Rochet, Nicole M., Dronca, Roxana S., Kottschade, Lisa A., Chavan, Rahul N., Gorman, Brian, Gilbertson, Julie R., Markovic, Svetomir N.
Natura: Artigo
Lingua:Inglês
Pubblicazione: Mayo Foundation 2012
Soggetti:
Brief Report
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC3538399/
https://ncbi.nlm.nih.gov/pubmed/23036672
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.mayocp.2012.07.006
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi